The Shirley Ryan Ability Lab is conducting a research study that will investigate a new approach for providing assistance for controlling an assistive device with limited interfaces for motor-impaired individuals.

Our studies aim to investigate potential Neuro-modulation Therapies with the help of an FDA approved drug in individuals with spinal cord injuries.

This is a clinical trial of people who have pain due to knee osteoarthritis at Northwestern University Feinberg School of Medicine in collaboration with Shirley Ryan AbilityLab. The study will last for about 20 weeks. 180 qualified participants will be randomly assigned in a 1:1:1 ratio (60 participants per group) to one of three treatment groups: duloxetine, celecoxib or placebo. Participants will have an X-ray, knee MRI, brain MRI, blood draws, pain sensitivity testing and will be asked to fill out questionnaires. The purpose of this study is to predict which participants will respond to the treatment.

The purpose of this study is to evaluate the benefits of osseointegration (OI) on functional, biomechanical, and metabolic outcomes as well as user satisfaction and powered prosthesis control for individuals with a transfemoral amputation who receive target muscle reinnervation (TMR) and OI surgery.

This study is to study the effects of combined arm and leg cycling on an individual’s walking ability.